Two fusion genes SPON1-NRG2α and SPON1-TRIM29, though which is observed with extremely low frequency, have been recently identified in ovarian cancer [29, 30], suggesting the contribution of SPON1 in the pathogenesis of ovarian cancer. This evidence concerns the gene TRIM29 and ovarian carcinoma.